CIQ
SIGMA/SML0229 - ≥98% (HPLC)
Synonym: (3-
CAS Number: 486427-17-2
Empirical Formula (Hill Notation): C26H26ClNO5
Molecular Weight: 467.94
Linear Formula: C26H26ClNO5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C26H26ClNO5/c1-30-20-7 |
| InChI key | VYMILMYEENZHAR-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1cc(ccc1)C(=O)N2CCc3c( |
| solubility | DMSO: ≥10 mg/mL at warmed to 60 °C |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | CIQ is a selective NR2C/NR2D-containing NMDA potentiator |
| Biochem/physiol Actions: | CIQ is positive allosteric modulator of NR2C/NR2D subunit containing NMDA receptors. CIQ increases channel opening frequency of recombinant NR2Cor NR2D containing receptors by two-fold (EC50 = 2.7 and 2.8 μM, respectively), with no effect on NR2A or NR2B subtypes. The compound does not alter the EC50 values for glutamate or glycine on channel opening. |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

